Corvidia
is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders... Read moreCorvidia
is a pharmaceutical firm that develops and commercializes novel therapeutics for the treatment of cardiorenal and chronic kidney disorders... Read more
News
Jun 25, 2020
Pharamceutical Technology
Corvidia: Novo Nordisk moves further into CV diseases with Corvidia acquisition
Jun 15, 2020
FinSMEs
Corvidia: Novo Nordisk to Buy Corvidia Therapeutics, for Up To $2.1 Billion
Jun 12, 2020
PharmaTimes
Corvidia: Novo snaps up cardio-renal group Corvidia
Jun 11, 2020
PE Hub Network
Corvidia: Sofinnova sells Corvidia Therapeutics for $2.1bn | PE Hub
Jan 29, 2020
StreetInsider
Press Release: Corvidia : Corvidia Therapeutics Announces Publication in Science Translational Medicine of Strategy for Lowering Triglycerides Using a Mimetic Peptide
Jan 08, 2020
PR Newswire
Press Release: Corvidia : Corvidia Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare Conference
Nov 14, 2019
StreetInsider
Press Release: Corvidia : Corvidia Therapeutics to Present New Data at the American Heart Association's Scientific Sessions 2019
Nov 06, 2019
PR Newswire
Press Release: Corvidia : Corvidia Therapeutics to Present New Data at ASN Kidney Week 2019
Jun 14, 2019
Pharmaceutical Business Review
Corvidia: Corvidia Therapeutics initiates phase 2b dose-finding study for Ziltivekimab
Jun 04, 2019
PR Newswire
Press Release: Corvidia : Corvidia Therapeutics to Participate in 2019 Jefferies Global Healthcare Conference
Corvidia Competitors
1
2
3
4
5
6
7
8
9
10